Corvidia Therapeutics to Present New Data at the American Heart Association's Scientific Sessions 2019

WALTHAM, Mass., Nov. 14, 2019 /PRNewswire/ -- Corvidia Therapeutics, a clinical stage company focused on the research, development and commercialization of transformative therapies in cardio-renal disease, will present at the American Heart Association's......
. .
Veröffentlicht von: Finanzen.at - Nachrichten Ticker - Thursday, 14 November

Share |